DP Tashkin, MD Altose, JE Connett, RE Kanner, WW Lee and RA Wise
UCLA School of Medicine, University of California at Los Angeles, Los Angeles, California 90095-1690, USA.

As part of a clinical trial of early intervention in chronic obstructive pulmonary disease (COPD) (the Lung Health Study), 5,733 smokers with mild to moderate airflow obstruction underwent methacholine challenge tests at baseline. All participants were randomized to receive either usual care (no intervention) or special intervention, consisting of intensive smoking cessation counseling and the prescription of a metered-dose inhaler containing either ipratropium bromide or placebo (two inhalations three times daily). For this report, we analyzed the relationship between baseline methacholine reactivity and subsequent change in lung function. Methacholine reactivity was expressed as a logarithmic function of the two-point slope of percent decline in FEV1 over the concentration of methacholine (LMCR). Using a random effects linear model, LMCR was found to be a strong predictor of change in FEV1% predicted, after controlling for baseline lung function, age, sex, baseline smoking history, and changes in smoking status. Significant interactions were found between reactivity and smoking behavior. In the first year, participants who quit smoking showed improvement in FEV1, whereas continuing smokers showed worsening, and between Years 1 and 5, lung function declined to a greater extent in continuing smokers than in sustained quitters. For both time periods, these quitter/smoker differences increased as a function of airway reactivity. These findings indicate that methacholine reactivity is an important predictor of progression of airway obstruction in continuing smokers with early COPD, independent of the baseline level of obstruct.

This article has been cited by other articles:

				D. D. Sin, P. S. Pahlavan, and S.F. P. Man Review: Surfactant protein D: A lung specific biomarker in COPD? Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 65 - 74. [Abstract] [PDF]

				P. Harber, D. P. Tashkin, M. Simmons, L. Crawford, E. Hnizdo, J. Connett, and for the Lung Health Study Group Effect of Occupational Exposures on Decline of Lung Function in Early Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 15, 2007; 176(10): 994 - 1000. [Abstract] [Full Text] [PDF]

				M. M E Gosman, H Marike Boezen, C. C van Diemen, J. B Snoeck-Stroband, T. S Lapperre, P. S Hiemstra, N. H T ten Hacken, J. Stolk, D. S Postma, and the GLUCOLD Study Group A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology Thorax, March 1, 2007; 62(3): 242 - 247. [Abstract] [Full Text] [PDF]

				L. Schirnhofer, B. Lamprecht, W. M. Vollmer, M. J. Allison, M. Studnicka, R. L. Jensen, and A. S. Buist COPD Prevalence in Salzburg, Austria: Results From the Burden of Obstructive Lung Disease (BOLD) Study Chest, January 1, 2007; 131(1): 29 - 36. [Abstract] [Full Text] [PDF]

				K. Crothers, A. A. Butt, C. L. Gibert, M. C. Rodriguez-Barradas, S. Crystal, A. C. Justice, and for the Veterans Aging Cohort 5 Project Team Increased COPD Among HIV-Positive Compared to HIV-Negative Veterans. Chest, November 1, 2006; 130(5): 1326 - 1333. [Abstract] [Full Text] [PDF]

				S. D. Ramsey and F. D. R. Hobbs Chronic Obstructive Pulmonary Disease, Risk Factors, and Outcome Trials: Comparisons with Cardiovascular Disease Proceedings of the ATS, September 1, 2006; 3(7): 635 - 640. [Abstract] [Full Text] [PDF]

				P. J. Barnes Against the dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases. Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 240 - 243. [Full Text] [PDF]

				O. Leclerc, V. Lagente, J-M. Planquois, C. Berthelier, M. Artola, T. Eichholtz, C. P. Bertrand, and F. Schmidlin Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice Eur. Respir. J., June 1, 2006; 27(6): 1102 - 1109. [Abstract] [Full Text] [PDF]

				J Vestbo and J C Hogg Convergence of the epidemiology and pathology of COPD Thorax, January 1, 2006; 61(1): 86 - 88. [Abstract] [Full Text] [PDF]

				Y. Chiba, M. Murata, H. Ushikubo, Y. Yoshikawa, A. Saitoh, H. Sakai, J. Kamei, and M. Misawa Effect of Cigarette Smoke Exposure In Vivo on Bronchial Smooth Muscle Contractility In Vitro in Rats Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 574 - 581. [Abstract] [Full Text] [PDF]

				K. F. Chung The Role of Airway Smooth Muscle in the Pathogenesis of Airway Wall Remodeling in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 347 - 354. [Abstract] [Full Text] [PDF]

				E. F. Hansen and J. Vestbo Bronchodilator reversibility in COPD: the roguish but harmless little brother of airway hyperresponsiveness? Eur. Respir. J., July 1, 2005; 26(1): 6 - 7. [Full Text] [PDF]

				H. J. van der Woude, J. Zaagsma, D. S. Postma, T. H. Winter, M. van Hulst, and R. Aalbers Detrimental Effects of {beta}-Blockers in COPD: A Concern for Nonselective {beta}-Blockers Chest, March 1, 2005; 127(3): 818 - 824. [Abstract] [Full Text] [PDF]

				A. E. Hegab, T. Sakamoto, W. Saitoh, H. H. Massoud, H. M. Massoud, K. M. Hassanein, and K. Sekizawa Polymorphisms of IL4, IL13, and ADRB2 Genes in COPD Chest, December 1, 2004; 126(6): 1832 - 1839. [Abstract] [Full Text] [PDF]

				T. S. Lapperre, J. B. Snoeck-Stroband, M. M.E. Gosman, J. Stolk, J. K. Sont, D. F. Jansen, H. A.M. Kerstjens, D. S. Postma, and P. J. Sterk Dissociation of Lung Function and Airway Inflammation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 1, 2004; 170(5): 499 - 504. [Abstract] [Full Text] [PDF]

				J.-Q. He, J. E. Connett, N. R. Anthonisen, P. D. Pare, and A. J. Sandford Glutathione S-Transferase Variants and Their Interaction with Smoking on Lung Function Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 388 - 394. [Abstract] [Full Text] [PDF]

				D. S. Postma and H. M. Boezen Rationale for the Dutch Hypothesis: Allergy and Airway Hyperresponsiveness as Genetic Factors and Their Interaction With Environment in the Development of Asthma and COPD Chest, August 1, 2004; 126(2_suppl_1): 96S - 104S. [Abstract] [Full Text] [PDF]

				F. C. Sciurba Physiologic Similarities and Differences Between COPD and Asthma Chest, August 1, 2004; 126(2_suppl_1): 117S - 124S. [Abstract] [Full Text] [PDF]

				M. R. Mazan, E. F. Deveney, S. DeWitt, D. Bedenice, and A. Hoffman Energetic cost of breathing, body composition, and pulmonary function in horses with recurrent airway obstruction J Appl Physiol, July 1, 2004; 97(1): 91 - 97. [Abstract] [Full Text] [PDF]

				J. C. Hogg, F. Chu, S. Utokaparch, R. Woods, W. M. Elliott, L. Buzatu, R. M. Cherniack, R. M. Rogers, F. C. Sciurba, H. O. Coxson, et al. The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease N. Engl. J. Med., June 24, 2004; 350(26): 2645 - 2653. [Abstract] [Full Text] [PDF]

				E. R. Sutherland and R. M. Cherniack Management of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., June 24, 2004; 350(26): 2689 - 2697. [Full Text] [PDF]

				D. C. Grootendorst and K. F. Rabe Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2004; 1(2): 77 - 87. [Abstract] [Full Text] [PDF]

				N. R. Anthonisen Lessons from the Lung Health Study Proceedings of the ATS, April 1, 2004; 1(2): 143 - 145. [Full Text] [PDF]

				P.J. Barnes, S.D. Shapiro, and R.A. Pauwels Chronic obstructive pulmonary disease: molecular and cellularmechanisms Eur. Respir. J., October 1, 2003; 22(4): 672 - 688. [Abstract] [Full Text] [PDF]

				R. A. Wise, R. E. Kanner, P. Lindgren, J. E. Connett, M. D. Altose, P. L. Enright, and D. P. Tashkin The Effect of Smoking Intervention and an Inhaled Bronchodilator on Airways Reactivity in COPD: The Lung Health Study Chest, August 1, 2003; 124(2): 449 - 458. [Abstract] [Full Text] [PDF]

				L Joos, T D Weir, J E Connett, N R Anthonisen, R Woods, P D Pare, and A J Sandford Polymorphisms in the {beta}2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers Thorax, August 1, 2003; 58(8): 703 - 707. [Abstract] [Full Text] [PDF]

				G.F. Joos and B. O'Connor Indirect airway challenges Eur. Respir. J., June 1, 2003; 21(6): 1050 - 1068. [Abstract] [Full Text] [PDF]

				S.T. Weiss, D.L. DeMeo, and D.S. Postma COPD: problems in diagnosis and measurement Eur. Respir. J., June 1, 2003; 21(41_suppl): 4S - 12s. [Abstract] [Full Text] [PDF]

				H Sugiura, M Ichinose, S Yamagata, A Koarai, K Shirato, and T Hattori Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD Thorax, April 1, 2003; 58(4): 299 - 305. [Abstract] [Full Text] [PDF]

				J.-Q. He, J. E. Connett, N. R. Anthonisen, and A. J. Sandford Polymorphisms in the IL13, IL13RA1, and IL4RA Genes and Rate of Decline in Lung Function in Smokers Am. J. Respir. Cell Mol. Biol., March 1, 2003; 28(3): 379 - 385. [Abstract] [Full Text] [PDF]

				E. Eden, J. Hammel, F. N. Rouhani, M. L. Brantly, A. F. Barker, A. S. Buist, R. J. Fallat, J. K. Stoller, R. G. Crystal, and G. M. Turino Asthma Features in Severe {alpha}1-Antitrypsin Deficiency: Experience of the National Heart, Lung, and Blood Institute Registry Chest, March 1, 2003; 123(3): 765 - 771. [Abstract] [Full Text] [PDF]

				G T Verhoeven, J P J J Hegmans, P G H Mulder, J M Bogaard, H C Hoogsteden, and J-B Prins Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness Thorax, August 1, 2002; 57(8): 694 - 700. [Abstract] [Full Text] [PDF]

				T. L. CROXTON, G. G. WEINMANN, R. M. SENIOR, and J. R. HOIDAL Future Research Directions in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2002; 165(6): 838 - 844. [Full Text] [PDF]

				L. J. DOWSON, P. J. GUEST, and R. A. STOCKLEY Longitudinal Changes in Physiological, Radiological, and Health Status Measurements in alpha 1-Antitrypsin Deficiency and Factors Associated with Decline Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1805 - 1809. [Abstract] [Full Text] [PDF]

				C. TAUBE, O. HOLZ, M. MUCKE, R. A. JORRES, and H. MAGNUSSEN Airway Response to Inhaled Hypertonic Saline in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1810 - 1815. [Abstract] [Full Text] [PDF]

				A E Tattersfield and T W Harrison Inhaled steroids for COPD? Thorax, September 1, 2001; 56(90002): ii2 - 6. [Full Text] [PDF]

				J Vestbo and E F Hansen Airway hyperresponsiveness and COPD mortality Thorax, September 1, 2001; 56(90002): ii11 - 14. [Full Text] [PDF]

				C. D. POIRIER, N. INHABER, R. G. LALONDE, and P. ERNST Prevalence of Bronchial Hyperresponsiveness Among HIV-Infected Men Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 542 - 545. [Abstract] [Full Text] [PDF]

				P. J. Barnes Chronic Obstructive Pulmonary Disease N. Engl. J. Med., July 27, 2000; 343(4): 269 - 280. [Full Text] [PDF]

				P. D. SCANLON, J. E. CONNETT, L. A. WALLER, M. D. ALTOSE, W. C. BAILEY, A. SONIA BUIST, and D. P.T. f. t. e Lung Health Study Research&n Smoking Cessation and Lung Function in Mild-to-Moderate Chronic Obstructive Pulmonary Disease . The Lung Health Study Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 381 - 390. [Abstract] [Full Text]

				P J STERK, H W F M DE GOUW, F L M RICCIARDOLO, and K F RABE Exhaled nitric oxide in COPD: glancing through a smoke screen Thorax, July 1, 1999; 54(7): 565 - 567. [Full Text]

				P. J Barnes Genetics and pulmonary medicine bullet  9: Molecular genetics of chronic obstructive pulmonary disease Thorax, March 1, 1999; 54(3): 245 - 252. [Full Text]

				C H Wong and A H Morice Cough threshold in patients with chronic obstructive pulmonary disease Thorax, January 1, 1999; 54(1): 62 - 64. [Abstract] [Full Text]

				D. S. POSTMA and H. A. M. KERSTJENS Characteristics of Airway Hyperresponsiveness in Asthma and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S187 - S192. [Abstract] [Full Text] [PDF]

				R. M. SENIOR and N. R. ANTHONISEN Chronic Obstructive Pulmonary Disease (COPD) Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): S139 - S147. [Full Text] [PDF]

				P. HODGINS, P. K. HENNEBERGER, M.-L. WANG, and E. L. PETSONK Bronchial Responsiveness and Five-year FEV1 Decline . A Study in Miners and Nonminers Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1390 - 1396. [Abstract] [Full Text]